Atlas Trials

Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers

Clinical trial NCT03625219 · COMPLETED

Trial details

NCT number
NCT03625219
Sponsor
Innovaderm Research Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Delayed Type Hypersensitivity
Start date
2018-07-26
Primary completion
2020-03-12
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.